Updated Date: Tue, 31 Dec 2024 00:00:00 EST
Updated Date: Tue, 31 Dec 2024 00:00:00 EST
Updated Date: Tue, 31 Dec 2024 00:00:00 EST
New FDA-approved schizophrenia treatment shows promise in clinical trials
Investment to support RNA therapeutics for epilepsy and neurological disorders
Updated Date: Tue, 31 Dec 2024 00:00:00 EST
According to a new study, ketamine use has risen significantly since 2015. The results highlight the need for […]
Updated Date: Tue, 31 Dec 2024 00:00:00 EST
Researchers at discovered a critical vulnerability in drug-resistant bacteria: zinc — or a lack thereof.
OAV101 IT expands potential for type II SMA patients